Infographics

31. Approaches To CMC Involvement Across Drug Development 9/18/2018

    In Q42017, ISR interviewed fifteen tenured CMC professionals at top 50 Pharma companies to learn when during the drug development cycle CMC has its greatest involvement and influence. 

32. Small Molecule Outsourcing Drivers 7/16/2018

    In Q42017, ISR surveyed sponsors who outsource small molecule API and small molecule drug product manufacturing to inquire about their company’s main driver for working with contract manufacturers.

33. Small Molecule API Contract Manufacturer Loyalty 6/25/2018

    In Q42017, ISR surveyed 227 sponsors who outsource small molecule API to gain insight into customer loyalty. CMO loyalty is computed as an index that consists of overall satisfaction, willingness to recommend, and the likelihood of using the contract manufacturer again. The data below show companies with ten or more responses from recent users and an industry average derive from all CMOs included in the research; their loyalty component scores are aggregated, averaged and then weighted based on the number of customer interactions.

34. Benefits Of Using Preferred Providers For Clinical Development Outsourcing 5/22/2018

    Results from a Q1 2018 ISR survey of 117 outsourcers at biopharmaceutical sponsors regarding the use and performance of a variety of clinical development outsourcing models.

35. Preferred Pharmaceutical Service Providers Use 11/16/2017

    This infographic provides an overview of preferred provider arrangements with research, software, and manufacturing organizations by presenting data on preferred provider use, quantity, and selection drivers.

36. Improving Manufacturing Outsourcing Relationships

    In Q4, 2018, ISR asked 100 sponsors who outsource manufacturing about several different scenarios that could potentially improve outsourcing relationships. The data below show how each of the scenarios panned out. A key common element across the most likely scenarios—communication. 

37. Customer Loyalty In Small Molecule Drug Product Manufacturing

    In Q42020, ISR surveyed 123 sponsors who outsource small molecule drug product to gain insight into customer loyalty. CMO loyalty is computed as an index that consists of overall satisfaction, willingness to recommend, and the likelihood of using the contract manufacturer again.

38. Outsourcers' CMO Preferences

    In Q4, 2019, ISR asked 676 buyers of outsourced manufacturing services about which types of CMOs their organization prefers, large, global CMOs with broad capabilities or Small, niche CMOs with highly specialized capabilities. Respondents’ preference leans towards the big guys. 44% agree-strongly agree that their organization prefers large, global CMOs as compared to 28% who indicate their organization prefers smaller, niche CMOs with specialized capabilities.

39. Outsourcing Practices And CMO Opinions

    60 percent of outsourced manufacturing buyers say a focus on innovative treatments impact their outsourcing practices. Half prefer large global CMOs, 40 percent prefer CMOs with specialized capabilities.